Core Insights - SBC Medical Group Holdings reported a revenue decrease of 18% year-over-year for Q3 2025, primarily due to restructuring initiatives and a revised fee structure for clinic services [3][5][8] - Despite the revenue decline, the company saw significant improvements in profitability, with net profit rising by 353% year-over-year, driven by lower operating expenses [4][6][8] - The company aims to pursue sustainable growth by focusing on high-quality solutions and expanding its multi-brand initiatives in dermatology [5][12] Q3 2025 Financial Results - Total revenues for Q3 2025 were $43 million, an 18% decrease from the previous year [5][8] - Income from operations increased by 15% year-over-year to $16 million [4][8] - Net income attributable to SBC Medical Group was $13 million, compared to $3 million in Q3 2024 [6][8] - EBITDA for the quarter was $17 million, reflecting a 12% increase, with an EBITDA margin of 38% [7][8][21] - The number of franchise locations increased to 258, up by 34 from the previous year, and the customer count reached 6.5 million, a 14% year-over-year increase [8][9] Year-to-Date 2025 Highlights - For the nine months ended September 30, 2025, total revenues were $134 million, a 17% decrease year-over-year [9] - Net income for the nine-month period was $37 million, down 8% from the previous year [9] - EBITDA for the nine months was $57 million, also a 17% decrease, with an EBITDA margin of 42% [9][21] Future Outlook - The company plans to continue its focus on delivering high-quality solutions and expanding its presence in overseas markets, particularly in dermatology [5][12]
SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results